NCT06414967 · RECRUITING

Study to Evaluate Music Therapy on Irritability and Impulsivity in Patients With Huntington's Disease (MUSIC-HD)

This small pilot study is testing whether a digital music therapy tool, used alongside usual care, can ease irritability and impulsivity in 15 people with early-stage Huntington's disease. Everyone gets the music. It is a pilot with no phase label, so it is an early look at feasibility, not proof that it works.

You may qualify if

  • Age >= 18 years
  • Huntington disease genetically confirmed by the presence of at least 35 repeats of the CAG triplet in exon 1 of the HTT gene
  • UHDRS (Unified Huntington's disease Rating Scale) score \<= 5 with a diagnostic confidence score =4
  • Absence of significant cognitive impairment MoCA >=24
  • Stable drug therapy in the 28 days prior inclusion and during the study
  • Without legal tutors or subordination
  • Affiliated to a health insurance system as required by the French law on biomedical research
  • Written informed consent for participation in the study

You're excluded if

  • Inability to give free and informed consent for study participation
  • Significant hearing impairment
  • Participating to another study the day of enrollement
  • Persons benefiting from enhanced protection, i.e.persons deprived of their liberty by a judicial or administrative decision, adults under legal and finally patients in a vital emergency situation.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-12-29

View full record on ClinicalTrials.gov

All APOE4 clinical trials